# A Research Study Looking at How Faster Aspart Injected in Double Concentration Works in the Body of People With Type 1 Diabetes Mellitus

> **NCT03723759** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 56 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Faster Aspart 200 U/mL
- **DRUG:** Faster aspart 100 U/mL

## Key facts

- **NCT ID:** NCT03723759
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-26
- **Primary completion:** 2019-03-21
- **Final completion:** 2019-03-27
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2020-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03723759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03723759, "A Research Study Looking at How Faster Aspart Injected in Double Concentration Works in the Body of People With Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03723759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*